Atlas Trials

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)

Clinical trial NCT01170650 · TERMINATED

Trial details

NCT number
NCT01170650
Sponsor
Endocyte
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2011-04-22
Primary completion
2015-05-31
Enrollment
441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.